Blog

Colon cancer and rectal cancer are often grouped together as colorectal cancer, but they aren’t the same disease, and the distinction matters more than most patients realise. Colon cancer develops in the longer upper section of the large intestine, while rectal cancer arises in the final few inches before the anus. That difference in location changes the symptoms a patient notices, the surgery involved, and whether radiotherapy is part of the plan, which is why an accurate diagnosis of exactly where the tumour sits shapes everything that follows. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Patients tend to think colorectal cancer is one condition, but where the tumour sits genuinely changes how we treat it. A rectal cancer often needs radiotherapy before surgery because of its confined position in the pelvis, whereas a colon cancer usually goes straight to surgery. Pinpointing the location accurately is the first real treatment decision.” How Do Colon and Rectal Cancer Differ? The two share an origin in the large bowel but diverge in almost every practical way. Factor Colon Cancer Rectal Cancer Location Upper large intestine Final few inches before anus Common symptoms Bowel habit change, anaemia Rectal bleeding, narrow stools Primary treatment Surgery first Often radiotherapy before surgery Surgical challenge More accessible Confined pelvic space Stoma risk Lower Higher in low rectal tumours Sitting higher in the large intestine, colon cancer tends to announce itself through changes in bowel habits, bloating, or unexplained anaemia from slow chronic blood loss. Rectal cancer makes itself known differently, more often through visible rectal bleeding, a sense of incomplete emptying, or stools that become noticeably narrow as the tumour grows. Because the rectum sits in a tight pelvic space, its surgery is technically harder and frequently needs radiotherapy beforehand to shrink the tumour and protect surrounding structures. Colon tumours, being more accessible, usually go to surgery first, with chemotherapy added afterward depending on the stage and node involvement. Pinpointing the location and stage accurately is where a colorectal cancer specialist sets the treatment direction before anything begins. Why Does the Distinction Matter for Treatment? Location dictates the treatment sequence, the surgical risk, and the patient’s long-term outlook. Treatment order changes with location, since rectal cancer often starts with radiotherapy and chemotherapy to shrink the tumour, while colon cancer typically begins with surgical removal. The risk of a stoma differs, being considerably higher in low rectal tumours close to the anus than in colon cancers higher up the tract. Follow-up and recurrence patterns vary, with rectal cancer carrying a higher local recurrence risk that demands closer pelvic surveillance after treatment. Early detection helps both equally, because a tumour caught before it spreads is more likely to be treatable through less invasive means regardless of where it sits. Catching either type early depends entirely on timely screening, and knowing who should be screened is the starting point. Read more on colon cancer screening to understand who needs screening and when early detection changes the outcome. Why Choose Dr. Vipulroy Rathod for Colorectal Cancer? Dr. Vipulroy Rathod has been diagnosing and staging colorectal cancers at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 is particularly valuable for rectal tumours, where accurate local staging determines whether radiotherapy is needed before surgery. Patients get a precise diagnosis of tumour location and depth in a single workup rather than a series of scattered tests. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for colon and rectal cancer assessment and endoscopic diagnosis. Book Appointment Call now Frequently Asked Questions What is the difference between colon cancer and rectal cancer? Colon cancer develops in the longer upper part of the large intestine, while rectal cancer arises in the final few inches before the anus. Their location leads to different symptoms, treatment, and surgical approaches. Is rectal cancer more serious than colon cancer? Neither is inherently more serious, but rectal cancer is often harder to treat surgically due to its confined location in the pelvis and frequently requires combined radiotherapy and chemotherapy alongside surgery. Do colon and rectal cancer have different symptoms? Yes. Colon cancer often causes changes in bowel habits, bloating, and anaemia, while rectal cancer more commonly causes rectal bleeding, a feeling of incomplete emptying, and narrow stools. Are colon and rectal cancer treated the same way? Not entirely. Both may need surgery and chemotherapy, but rectal cancer more often requires radiotherapy before surgery due to its location, while colon cancer is usually treated with surgery first. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

When a lesion is too large for a clean EMR but doesn’t justify the time and risk of a full ESD, hybrid endoscopy offers a middle path. It combines techniques in a single procedure, typically using a partial submucosal dissection to free the difficult edges of a lesion before snaring the rest, which captures the strengths of both methods at once. The aim is a more complete removal than EMR can manage on its own, achieved faster and with less risk than committing to ESD across the entire lesion. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Hybrid endoscopy exists because not every lesion fits neatly into one technique. Some are too big for a tidy snare resection but don’t need a full dissection either. Combining the two lets us remove the lesion completely without exposing the patient to unnecessary procedure time or perforation risk.” How Does Hybrid Endoscopy Work? The technique borrows the most useful parts of EMR and ESD and applies each where it does the most good. Dissecting only the difficult margins with an ESD knife frees the edges of a lesion that a snare alone couldn’t capture cleanly, which is where the hybrid approach earns its advantage. The bulk of the lesion then comes out through standard snare resection after a submucosal lift, keeping the procedure considerably faster than dissecting the entire area. Because the hardest part is handled by precise dissection, the overall perforation risk drops compared to attempting a difficult EMR on a lesion that was never well suited to snaring. For lesions in the 2 to 3 cm range that sit awkwardly between techniques, this combined route often delivers the most complete removal without overcommitting to a lengthy full dissection. Deciding whether a lesion suits this approach needs accurate assessment, which is where a specialist in hybrid endoscopy evaluates size, depth, and position before choosing the technique. When Is Hybrid Endoscopy the Right Choice? It isn’t a default, and the decision comes down to matching the lesion to what each technique does best. Lesions that fall between EMR and ESD territory are the clearest candidates, being too large for confident piecemeal snaring yet not complex enough to warrant a full dissection from edge to edge. Where en bloc removal matters but isn’t fully achievable, hybrid technique improves completeness over EMR without demanding the time and skill ceiling that complete ESD requires. If a lesion sits in a technically awkward location, combining methods can reach margins that a single technique would struggle with, which keeps the patient out of surgery. Once EUS staging confirms the lesion is mucosal and hasn’t invaded deeper layers, hybrid resection becomes a reasonable option rather than a referral for surgical removal. Understanding how any of these endoscopic procedures actually unfolds for the patient helps put the technique in context. Read more on endoscopy steps to understand what happens during an endoscopic procedure from start to finish. Why Choose Dr. Vipulroy Rathod for Hybrid Endoscopy? Dr. Vipulroy Rathod has been performing advanced therapeutic endoscopy at Fortis Hospital Mulund for over 30 years, and combining techniques like EMR and ESD demands exactly the kind of judgment that comes from that volume. His EUS practice since 1998 means lesions are staged accurately before any resection decision, so the technique chosen actually fits the lesion in front of him. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for hybrid endoscopy and advanced endoscopic lesion removal. Book Appointment Call now Frequently Asked Questions What is hybrid endoscopy? Hybrid endoscopy combines two or more endoscopic techniques, such as EMR and ESD, in a single procedure to remove complex lesions more safely and efficiently than either method alone. When is hybrid endoscopy used? Hybrid endoscopy is used for large or technically difficult lesions where a single technique would be slower, riskier, or less complete, combining the strengths of different methods in one session. Is hybrid endoscopy safer than ESD alone? For suitable lesions, hybrid endoscopy can reduce procedure time and perforation risk compared to full ESD while still achieving more complete removal than EMR alone. Who should perform hybrid endoscopy? Hybrid endoscopy should be performed by an experienced therapeutic endoscopist, as combining techniques requires advanced skill and accurate lesion assessment before the procedure. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Liver fibrosis is the scarring that develops when the liver is repeatedly inflamed or injured, gradually replacing healthy tissue with stiff scar tissue that impairs how the organ functions. It progresses through defined stages, from no fibrosis at all to full cirrhosis, and the stage at diagnosis determines whether the damage can still be reversed. The difficulty is that fibrosis is silent until late, so most patients have no idea it’s developing, which is exactly why accurate staging matters before symptoms ever appear. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Liver fibrosis is largely a silent disease, and most patients are at stage IV when the damage is already irreversible. Accurate assessment at the correct stage is vital, because early intervention can slow progression, help the liver heal, and prevent the life-threatening complications that come later.” How Is Liver Fibrosis Staged? Staging answers the one question that changes everything: how much scarring has already happened, and is it still reversible. Stage What It Means F0 No fibrosis, healthy liver F1 Mild fibrosis, minimal scarring F2 Moderate fibrosis, scarring spreading F3 Severe fibrosis, extensive scarring F4 Cirrhosis, irreversible damage Measuring liver stiffness through FibroScan has become the first-line approach, because it produces a fibrosis stage in a few painless minutes using transient elastography rather than a needle, which is why it’s now the default for most patients. Blood-based scores such as FIB-4 and APRI combine routine markers into a fibrosis estimate, useful as a screening filter that decides who genuinely needs imaging and who doesn’t. Where the non-invasive results don’t agree or the picture stays unclear, liver biopsy remains the reference standard, sampling tissue directly to settle the stage with certainty. EUS earns its place in selected cases, assessing the complications like portal hypertension that begin to develop as fibrosis pushes toward the cirrhotic end of the scale. Working out which of these a given patient actually needs is where a liver cirrhosis specialist guides the workup rather than reading a single stiffness number in isolation. Why Does Staging Fibrosis Matter So Much? The stage isn’t just a label on a report, it sets the entire direction of treatment and tells you whether the liver still has a route back. At F1 and F2, the liver can still heal, so treating the underlying cause at this point often reverses the scarring, which is the strongest practical argument there is for catching fibrosis before it advances. Moving from one stage to the next changes the monitoring interval, the urgency, and the intensity of treatment, meaning the gap between F2 and F3 carries far more clinical weight than the numbers alone suggest. Once a patient reaches F4, the focus shifts away from reversal and toward surveillance for liver cancer and management of the complications that cirrhosis brings with it. No stage improves while its cause goes untreated, which is why fibrosis driven by fatty liver, alcohol, or hepatitis won’t stabilise unless that underlying driver is addressed alongside the staging itself. Since metabolic disease drives so much of the fibrosis seen today, the way fatty liver and diabetes feed each other is worth understanding. Read more on fatty liver to see how metabolic conditions like diabetes accelerate fibrosis progression. Why Choose Dr. Vipulroy Rathod for Liver Fibrosis? Dr. Vipulroy Rathod has been staging and managing liver fibrosis at Fortis Hospital Mulund for over 30 years, pairing FibroScan with EUS since 1998 to assess both the scarring itself and the complications that follow as it advances. Patients told they simply have mild fatty liver often find, on accurate staging, exactly where their fibrosis sits and how much of it is still reversible. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for liver fibrosis assessment and staging. Book Appointment Call now Frequently Asked Questions What is liver fibrosis? Liver fibrosis is the build-up of scar tissue in the liver caused by ongoing inflammation or injury, which gradually replaces healthy tissue and impairs liver function if it progresses. How is liver fibrosis staged? Liver fibrosis is staged from F0 to F4, where F0 means no fibrosis and F4 indicates cirrhosis. Staging is assessed through FibroScan, blood-based scores, or liver biopsy. Can liver fibrosis be reversed? Early-stage fibrosis can improve or reverse if the underlying cause is treated, but advanced fibrosis and cirrhosis at stage F4 are largely irreversible. What is the best test for liver fibrosis? FibroScan is the most widely used non-invasive test for staging fibrosis by measuring liver stiffness, while liver biopsy remains the reference standard when results are unclear. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Gallbladder cancer is diagnosed through a sequence of imaging that starts with ultrasound and escalates to CT, MRI, and EUS depending on what’s found. The difficulty is that early disease produces no specific symptoms, so a large share of cases turn up incidentally, either on a scan done for something else or on histology after a routine gallbladder removal. Accurate staging once a lesion is identified is what determines whether treatment is possible, which makes the diagnostic pathway as important as the finding itself. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Gallbladder cancer is one of the hardest GI cancers to catch early because the gallbladder doesn’t announce trouble until late. When a suspicious thickening or mass shows up, the priority is accurate staging, and that’s where EUS adds detail that a standard scan simply can’t provide.” What Tests Are Used to Diagnose Gallbladder Cancer? Diagnosis builds in steps, each test answering a question the previous one couldn’t. Ultrasound comes first, picking up gallbladder wall thickening, masses, or polyps that warrant further investigation, though it can’t confirm cancer on its own. CT and MRI map the extent, showing whether a tumour has spread to the liver, bile ducts, or distant sites, which is essential for staging once ultrasound raises suspicion. EUS adds the detail external scans miss, assessing tumour depth and nearby lymph nodes from inside the GI tract at a proximity no surface imaging can reach. When tissue confirmation is needed, EUS-guided fine needle aspiration samples the lesion directly, settling an ambiguous imaging picture without surgery. Getting this sequence right requires a gallbladder cancer specialist who can interpret each step and decide what the next investigation should be. Why Is Gallbladder Cancer So Often Found Late? The diagnostic challenge isn’t usually the tests themselves but how late the suspicion arises. No specific early symptoms exist. The vague right upper abdominal discomfort that gallbladder cancer produces is identical to ordinary gallstone disease, so it rarely triggers cancer-focused investigation. Many cancers surface incidentally on histology after a gallbladder is removed for gallstones, meaning the diagnosis arrives only once the organ is already out. Imaging overlap muddies the picture, because gallstones and chronic inflammation can mask or mimic an early tumour on ultrasound, delaying the escalation to CT or EUS. High-risk patients often go unmonitored, as those with large gallstones or gallbladder polyps frequently aren’t placed on the surveillance that would catch a developing cancer early. For patients dealing with gallbladder-related complications, understanding how endoscopic diagnosis works in the biliary system is a useful background. Read more on bile leakage to see how endoscopic techniques diagnose and manage biliary complications after gallbladder surgery. Why Choose Dr. Vipulroy Rathod for Gallbladder Cancer? Dr. Vipulroy Rathod has been diagnosing hepatobiliary cancers at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 gives him the staging tool most centres don’t deploy for gallbladder lesions that surface imaging can’t fully characterise. Patients with an ambiguous gallbladder finding often get a clear diagnosis and accurate stage in a single workup rather than a series of scattered scans. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for gallbladder cancer diagnosis and endoscopic staging. Book Appointment Call now Frequently Asked Questions How is gallbladder cancer diagnosed? Gallbladder cancer is diagnosed through ultrasound as the first step, followed by CT or MRI for staging, and EUS with fine needle aspiration for tissue confirmation and assessment of local spread. What is the most accurate test for gallbladder cancer? EUS provides the most accurate local staging by assessing tumour depth and lymph node involvement, and allows fine needle aspiration for tissue diagnosis when imaging findings are inconclusive. Can gallbladder cancer be detected on ultrasound? Ultrasound can detect gallbladder wall thickening, masses, or polyps suggestive of cancer, but further imaging with CT, MRI, or EUS is needed to confirm the diagnosis and stage the disease. Is gallbladder cancer often found incidentally? Yes. Many gallbladder cancers are found incidentally on histology after gallbladder removal for gallstones, or on imaging performed for an unrelated reason, rather than through symptoms. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Open surgery is no longer the default for colorectal cancer the way it was two decades ago. Early-stage tumours and large precancerous polyps are now routinely removed through the colonoscope itself, and even cases that do need an operation are often handled laparoscopically rather than through a large incision. What determines the route is stage, depth, and location, which makes accurate workup before treatment the single most important factor in keeping a patient out of open surgery. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “The patients who end up in open surgery are often the ones who presented late. Caught early, a colorectal cancer confined to the lining can frequently come out through the scope in a day procedure. The earlier we see it, the less invasive the treatment, which is the entire argument for screening.” What Are the Non-Surgical Treatment Options? The treatment route depends almost entirely on how early the cancer is caught. Removing the lesion endoscopically through EMR or ESD handles early cancers confined to the mucosa, taking the tumour out through the colonoscope with no incision and same-day discharge. Large or flat polyps that standard polypectomy can’t manage come out via EMR before they ever progress to invasive cancer. When a cancer sits slightly deeper but hasn’t spread, laparoscopic resection removes the affected segment through small keyhole incisions instead of an open laparotomy. For rectal cancers, transanal endoscopic approaches reach early lesions through the anus, avoiding both abdominal incisions and, in selected cases, a permanent stoma. Which of these applies comes down to staging, and a colorectal cancer specialist determines the least invasive route that still treats the disease completely. When Is Open Surgery Still Necessary? Not every case can avoid open surgery, and knowing the limits matters as much as knowing the options. Deep invasion into the bowel wall takes a cancer past what any endoscopic technique can safely remove, and resection becomes necessary. If lymph nodes are involved, the cancer has spread beyond a local problem, and surgery with node clearance is required regardless of how the primary lesion looks. Large or obstructing tumours blocking the bowel usually need surgical removal, often urgently, before endoscopic options can even be considered. Once a tumour is technically complex in its position or extent, open surgery offers the control that keyhole or endoscopic routes can’t reliably provide. Catching colorectal cancer before it reaches these stages is what keeps treatment minimally invasive, and that starts with knowing who needs screening. Read more on colon cancer screening to understand who should be screened and when early detection changes the treatment route entirely. Why Choose Dr. Vipulroy Rathod for Colorectal Cancer? Dr. Vipulroy Rathod has been treating colorectal cancer endoscopically at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 means the staging that decides between an endoscopic, laparoscopic, or open route happens accurately in the same workup. Patients referred for open surgery on lesions that were actually suitable for endoscopic removal frequently find a less invasive option available. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for colorectal cancer assessment and minimally invasive endoscopic treatment. Book Appointment Call now Frequently Asked Questions Can colorectal cancer be treated without open surgery? Yes. Early-stage colorectal cancers and large polyps can be removed endoscopically through EMR or ESD, while more advanced cases may be treated with laparoscopic surgery rather than open surgery. What is endoscopic treatment for colorectal cancer? Endoscopic treatment removes early colorectal cancers and precancerous polyps through a colonoscope using EMR or ESD, without any external incision and usually as a day procedure. When is open surgery still needed for colorectal cancer? Open surgery is needed when the cancer has invaded deeper bowel layers, spread to lymph nodes, or is too large or complex for endoscopic or laparoscopic removal. Is endoscopic colorectal cancer treatment safe? Yes. For suitable early-stage lesions, endoscopic removal is safe, avoids general anaesthesia in many cases, preserves the bowel, and allows same-day discharge with faster recovery than open surgery. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

EMR and ESD are both endoscopic techniques for removing early GI tumours without open surgery, but they aren’t interchangeable. EMR lifts and snares a lesion off in pieces, while ESD dissects beneath it to take the whole thing out in one specimen. The choice between them comes down to lesion size, depth, and whether the pathologist needs an intact margin, which means the better technique is the one matched correctly to the lesion rather than the one that’s better in the abstract. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Patients often ask which procedure is superior, and the honest answer is that it depends entirely on what we’re removing. A small polyp doesn’t need ESD. A large flat lesion where margins matter for staging shouldn’t have EMR. Getting that decision right before the procedure is what actually determines the outcome.” How Do EMR and ESD Differ? The two procedures share a goal but differ in how they reach it. Factor EMR ESD Removal method Snare, in pieces Dissection, single piece Best lesion size Under 2 cm Above 2 cm Specimen quality Fragmented En bloc, intact margins Procedure time Shorter Longer Recurrence risk Higher for large lesions Lower Snaring the lesion is how EMR works, lifting it with a submucosal injection and cutting it free, which suits smaller superficial lesions well. ESD dissects under the lesion with a fine knife, freeing it in one intact piece. That single specimen is what gives pathologists a clean margin to assess. For lesions above 2 cm, EMR usually means piecemeal removal, and fragmented specimens make accurate margin assessment harder and recurrence more likely. Where en bloc removal matters for staging, ESD is the better choice despite taking longer and demanding more technical skill. Choosing correctly needs accurate pre-procedure staging, which is where a specialist in endoscopic resection determines which technique fits the lesion in front of them. Which One Is Right for a Given Tumour? There’s no universally superior technique, only the right match for the lesion. Small, clearly superficial lesions do well with EMR. It’s faster, simpler, and carries a lower complication rate. Large or flat lesions belong to ESD, where en bloc removal gives a complete specimen and a markedly lower recurrence rate. If the lesion’s depth is uncertain, EUS staging settles it before anything is cut, and that assessment often decides EMR versus ESD on its own. Once invasion beyond the mucosa is suspected, neither technique is appropriate and surgery becomes the safer route, which is why staging always precedes the resection decision. Understanding where these procedures sit within endoscopy’s broader treatment role helps put the choice in context. Read more on role of endoscopy to see how EMR and ESD fit alongside endoscopy’s wider diagnostic and treatment capabilities. Why Choose Dr. Vipulroy Rathod for EMR and ESD? Dr. Vipulroy Rathod has been performing both EMR and ESD at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 means the staging that decides between the two techniques happens accurately in the same workup rather than as guesswork. Patients referred for surgery on lesions that were actually suitable for endoscopic removal frequently find a less invasive route available. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for EMR, ESD, and endoscopic GI tumour removal. Book Appointment Call now Frequently Asked Questions What is the difference between EMR and ESD? EMR removes lesions in pieces using a snare, while ESD dissects beneath the lesion to remove it in a single piece, allowing more accurate margin assessment for larger or deeper lesions. Which is better for GI tumours, EMR or ESD? It depends on lesion size and depth. EMR suits smaller superficial lesions, while ESD is preferred for larger lesions above 2 cm or where en bloc removal is needed for accurate staging. Is ESD more risky than EMR? ESD carries a slightly higher risk of perforation and bleeding due to its complexity, but in experienced hands it offers higher complete resection rates and lower recurrence than EMR for suitable lesions. Can EMR and ESD remove early cancer? Yes. Both remove early-stage GI cancers confined to the mucosa, but ESD allows en bloc removal that gives pathologists a complete specimen for accurate margin and depth assessment. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Many IBD complications that once meant surgery are now treated through the endoscope. Strictures, dysplastic lesions, perianal abscesses, and acute bleeding in Crohn’s and ulcerative colitis patients can be managed in a day procedure that leaves the bowel intact. Surgery still has a place in IBD care, but for complications a scope can reach, it has stopped being the automatic first answer it used to be. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “IBD patients used to face surgery almost inevitably once complications developed. That’s no longer true in most cases. Balloon dilation, endoscopic resection, EUS-guided drainage these have changed the conversation from when do we operate to whether we need to operate at all, and for a lot of patients the answer is we don’t.” What Complications Can Endoscopy Now Manage? Four interventions account for most of the shift away from surgery. Balloon dilation opens short fibrous strictures in Crohn’s without resecting bowel. It can be repeated over years, which spares patients the cumulative damage of multiple surgeries. Removing dysplastic lesions in ulcerative colitis through EMR or ESD keeps patients out of the colectomy pathway, provided the lesion is well demarcated and confined to the mucosa on EUS. If a perianal or abdominal abscess develops in Crohn’s, EUS-guided drainage clears it through the rectal wall. No general anaesthetic, no external wound, much faster recovery than operative drainage. Acute bleeding during a flare gets controlled with APC or clipping at the bleeding point, sparing a patient with active colitis the substantially higher risk of emergency surgery. A specialist in IBD management can assess which of these applies before any surgical referral is made. How Does Endoscopy Monitor IBD Between Flares? Monitoring matters as much as treating. It’s how complications get caught early. Mucosal healing is the treatment target now, not symptom control, and only colonoscopy with biopsies can confirm it. A patient who feels fine may still have active inflammation underneath. Dysplasia surveillance in long-standing ulcerative colitis runs on a structured colonoscopy schedule. Regular biopsies catch early change that’s still treatable through the scope. Symptom improvement isn’t the same as mucosal healing. Endoscopic confirmation after starting a biologic tells you whether the drug is actually working, and the treatment decision changes accordingly. When Crohn’s affects small bowel beyond colonoscopic reach, capsule endoscopy or balloon-assisted enteroscopy covers the segments a standard scope can’t, so disease activity gets tracked across its full extent. A closer look at what colonoscopy finds in IBD, and where it falls short, is worth reading first. Read more on Crohn’s detection to see how colonoscopy fits into diagnosis and monitoring for Crohn’s disease. Why Choose Dr. Vipulroy Rathod for IBD? Dr. Vipulroy Rathod has been managing IBD endoscopically at Fortis Hospital Mulund for over 30 years, with EUS since 1998 adding a drainage and staging capability most IBD centres don’t deploy for perianal and abdominal complications. Patients referred for surgical opinions on strictures or colonic dysplasia often find an endoscopic route their previous gastroenterologist hadn’t explored. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for IBD endoscopic assessment, stricture management, and dysplasia surveillance. Book Appointment Call now Frequently Asked Questions Can endoscopy replace surgery for IBD? In many cases yes, with balloon dilation for strictures, EMR for dysplastic lesions, and EUS-guided drainage for abscesses addressing complications that previously required open surgery. What endoscopic procedures are used for IBD? Colonoscopy with biopsy for monitoring, balloon dilation for intestinal strictures, endoscopic mucosal resection for dysplasia, and EUS-guided drainage for abscesses are the main procedures used in IBD management. Is endoscopic treatment for IBD safe? Yes. Endoscopic procedures carry significantly lower risk than open surgery, with shorter recovery times and no need for general anaesthesia in most cases. Does endoscopy cure IBD? Endoscopy does not cure IBD but manages its complications and monitors disease activity and treatment response, reducing the need for surgical intervention in many patients. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Alcoholic liver disease and non-alcoholic fatty liver disease both deposit fat in the liver and can both progress to cirrhosis, but they arrive there through entirely different mechanisms and need different clinical approaches. ALD is driven by alcohol; NAFLD develops in people who drink little or none, tied instead to obesity, insulin resistance, and metabolic syndrome. With NAFLD now affecting an estimated 25 to 38% of the Indian adult population, confusing the two or missing either diagnosis carries real consequences for long-term liver health. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Both conditions are underdiagnosed because neither produces reliable symptoms until significant liver damage has already occurred. The patient with NAFLD often has no idea their liver is affected until a routine ultrasound picks it up, and by the time ALD causes clinical symptoms, the disease has frequently moved well past the fatty liver stage.” How Do ALD and NAFLD Differ? On ultrasound alone, a radiologist can’t always tell them apart; the distinction comes from clinical history, blood patterns, and staging investigations. Factor Alcoholic Liver Disease NAFLD Primary cause Heavy alcohol use Obesity, insulin resistance Typical patient Any adult with significant intake Diabetic, overweight, metabolic syndrome Key blood marker AST:ALT ratio above 2:1 ALT typically higher than AST Reversibility High if alcohol stopped early Reversible with weight loss in early stages Progression risk Faster with continued drinking Slower but accelerated by diabetes Sustained heavy alcohol use sets off a cycle of hepatic inflammation, fat accumulation, and progressive scarring that moves toward cirrhosis at a pace considerably faster than NAFLD, and the defining feature clinically is that the damage halts and partially reverses when drinking stops but accelerates sharply when it doesn’t. What makes NAFLD harder to catch is that the patients most at risk overweight, diabetic, dyslipidaemic don’t think of themselves as having a liver disease, and the metabolic drivers including central obesity, insulin resistance, and hypertension work together to push fibrosis forward even without any alcohol involvement, often across years of entirely normal liver function tests that provide false reassurance. When both conditions coexist in the same patient, which happens more often than expected in someone with metabolic syndrome who also drinks at harmful levels, the AST to ALT ratio provides a useful but imperfect guide, and a FibroScan or biopsy becomes the investigation that separates a clinical assumption from an actual answer. Getting staging right before committing to a management plan matters because the patient who gets lifestyle advice for what turns out to be advanced fibrosis, and the patient who gets referred for a transplant workup when their disease was still reversible, both suffered from the same failure of accurate baseline assessment. A fatty liver finding on ultrasound needs proper staging rather than a repeat scan in six months a fatty liver specialist can determine what’s actually driving it and how far along the fibrosis has already progressed. How Is Each Condition Managed? Each has one non-negotiable intervention, and everything else builds around it. Stop drinking. In ALD that’s not one recommendation among several it’s the treatment, and continued alcohol use in the context of alcoholic hepatitis or early cirrhosis carries a mortality risk no pharmacological intervention currently overcomes without abstinence running alongside it. Achieving 7 to 10% body weight reduction is the most reliably evidence-backed intervention in NAFLD, producing measurable histological improvement in both hepatic steatosis and fibrosis across multiple patient populations and remaining first-line ahead of pharmacotherapy even for patients who arrive convinced a medication will do what lifestyle hasn’t yet managed. Thiamine, folate, and protein deficiencies are routine findings in patients with ALD and compound the liver damage if not corrected alongside cessation, which is why the patient who stops drinking but receives no nutritional input often fails to recover as expected despite doing the one thing that should theoretically be enough. GLP-1 receptor agonists and SGLT-2 inhibitors have shown hepatic benefit well beyond glycaemic control in recent NAFLD data, and for diabetic patients in particular the most productive treatment conversation is increasingly the one that happens between the gastroenterologist and the treating endocrinologist rather than either working through it independently. Both conditions raise long-term GI cancer risk if they progress to cirrhosis, and the metabolic factors that drive NAFLD connect to broader cancer risk worth understanding. Read more on colon cancer screening to see how overlapping metabolic risk factors including fatty liver influence long-term GI cancer risk. Why Choose Dr. Vipulroy Rathod for Liver Disease? Dr. Vipulroy Rathod has been managing ALD and NAFLD at Fortis Hospital Mulund for over 30 years, regularly seeing patients who’ve had fatty liver flagged on imaging with no staging of how advanced the fibrosis actually is. FibroScan assessment and EUS when indicated quantify structural damage accurately in the same workup, and patients who arrive managing what they believe is mild fatty liver frequently leave with a clearer picture of where their disease sits and what’s realistically needed. Physicians from 35 countries have trained under his approach at Fortis. Book your consultation today with one of India’s most experienced specialists for alcoholic liver disease and NAFLD assessment, staging, and management. Book Appointment Call now Frequently Asked Questions What is the main difference between alcoholic liver disease and NAFLD? Alcoholic liver disease is caused by heavy alcohol consumption, while NAFLD occurs in people who drink little or no alcohol and is driven by obesity, insulin resistance, and metabolic syndrome. Can NAFLD progress to cirrhosis? Yes. NAFLD can progress through steatohepatitis and fibrosis to cirrhosis and liver failure, particularly in patients with diabetes, obesity, or metabolic syndrome who do not modify their lifestyle. How is alcoholic liver disease diagnosed? Diagnosis involves a detailed alcohol history, liver function tests, ultrasound, and in some cases FibroScan or liver biopsy to assess the degree of fibrosis and rule out concurrent causes. Is fatty liver reversible? Early-stage fatty liver in both ALD and NAFLD is potentially reversible with alcohol cessation or weight loss respectively, but once significant fibrosis develops the damage becomes

Gallbladder cancer is one of the more deceptive GI malignancies because it produces no reliable symptoms in its early stages, and the signs that do appear upper abdominal discomfort, nausea, mild jaundice overlap so closely with common biliary complaints that most patients are already at an advanced stage before the diagnosis is made. India carries one of the highest gallbladder cancer incidence rates in the world, particularly in northern and eastern states, which makes awareness of the risk profile and early clinical signals more relevant here than almost anywhere else. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “Gallbladder cancer is frequently found incidentally on imaging done for something else, or on histology after a routine cholecystectomy. The patients who come in with symptoms are often already past the stage where curative options apply, which is exactly why high-risk individuals need monitoring rather than waiting for a symptom to act on.” What Are the Early Signs of Gallbladder Cancer? The clinical picture in early gallbladder cancer is thin, which is what makes it hard to catch without active surveillance in patients who carry known risk factors. Pain in the upper right abdomen that comes and goes, particularly after fatty meals, tends to get managed as a gallstone symptom for months before imaging is ordered, and in patients who’ve had gallstones for years the new pattern often gets folded into the existing diagnosis rather than investigated as a change from it. Jaundice appearing without an obvious cause yellowing of the skin or whites of the eyes, sometimes with pale stools and dark urine points to biliary obstruction and in a patient over 50 with a gallstone history warrants urgent imaging rather than watchful waiting, because an obstructing gallbladder tumour can produce exactly this picture in its early spread to the bile ducts. Nausea and loss of appetite that hasn’t resolved over several weeks, particularly when accompanied by early satiety or a vague heaviness in the right upper quadrant, is a combination that’s easy to attribute to acidity or gastritis but that in practice shows up consistently in early gallbladder cancer patients before anything more specific develops. Unintended weight loss without a dietary explanation, running alongside any of the above, is the signal that turns a biliary complaint into an oncological workup, and the patients in whom it gets attributed to stress or busy schedules rather than investigated are the ones who tend to arrive late. These signs individually are nonspecific, but running together in a patient with gallstones or a prior polyp diagnosis, they warrant proper evaluation by a gallbladder cancer specialist rather than empirical management. Who Is at Risk and How Is It Detected? Risk in gallbladder cancer clusters around a well-defined set of factors, and knowing them is what determines who needs surveillance before symptoms appear. Gallstones, particularly large ones, carry the strongest association stones above 3 cm raise gallbladder cancer risk substantially compared to smaller stones, and patients who’ve had symptomatic gallstones for over a decade without cholecystectomy sit in a higher-risk category that warrants periodic imaging regardless of symptom status. Gallbladder polyps detected on ultrasound need size-based follow-up rather than a single normal report and discharge, because polyps above 1 cm carry meaningful malignant potential and those growing on serial imaging need histological assessment rather than continued surveillance. Porcelain gallbladder, a calcification of the gallbladder wall found incidentally on imaging, was historically considered a high cancer risk, and while the association is more nuanced than previously thought, patients with this finding need specialist review to determine whether the calcification pattern is one that warrants cholecystectomy. Women over 50 from northern India carry a particularly elevated baseline risk due to a combination of dietary, genetic, and environmental factors that epidemiological data has consistently identified, and this group benefits from lower investigation thresholds when biliary symptoms appear. Ultrasound is the starting point for detection, but EUS gives far more precise local staging information when a lesion is found. Read more on cancer warning signs to understand which clinical presentations across GI cancers need urgent imaging rather than a repeat clinic visit. Why Choose Dr. Vipulroy Rathod for Gallbladder Cancer? Dr. Vipulroy Rathod has been managing hepatobiliary and GI cancers at Fortis Hospital Mulund for over 30 years, and gallbladder cancer in particular has formed a significant part of his referred caseload given India’s elevated incidence rates, which means the clinical pattern recognition that separates an early finding from a late one is something his practice sees frequently enough to act on rather than reason through from first principles each time. Physicians from 35 countries have trained under his approach at Fortis, and that depth of experience shows most clearly in the complexity of the cases his team handles routinely. Book your consultation today with one of India’s most experienced specialists for gallbladder cancer risk assessment, early detection, and endoscopic staging. Book Appointment Call now Frequently Asked Questions What are the early signs of gallbladder cancer? Upper abdominal pain on the right side, nausea, unexplained weight loss, and jaundice are among the earliest signs, though many patients have no symptoms at all in the initial stages. Is gallbladder cancer related to gallstones? Yes. Long-standing gallstones, particularly large ones above 3 cm, are one of the most significant risk factors, though most people with gallstones do not develop cancer. How is gallbladder cancer diagnosed? Ultrasound is typically the first investigation, followed by CT or MRI for staging, and EUS for assessing local spread and lymph node involvement with greater accuracy than external imaging. Can gallbladder cancer be caught early? It can, but most cases are diagnosed incidentally during cholecystectomy or on imaging done for another reason, so high-risk patients with large gallstones or gallbladder polyps should be monitored regularly. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.

Colorectal cancer is consistently diagnosed at a later stage in India than necessary, not because the disease hides well but because its earliest symptoms are ones most people have a ready explanation for. Blood in the stool becomes a piles problem. Months of altered bowel habits become a diet conversation. The result is that patients arrive at a gastroenterologist with a disease that’s had time to grow while every individual symptom was being managed as something else entirely. According to Dr. Vipulroy Rathod, Gastroenterologist in Mumbai, “The symptoms patients ignore most often are the ones I see most frequently in late-stage referrals. Rectal bleeding, unexplained weight loss, a change in stool frequency that’s been going on for weeks none of these should be dismissed without a proper workup, and yet most patients wait six months before mentioning them to a doctor.” Which Symptoms Do Patients Most Often Dismiss? These four presentations account for the majority of delayed diagnoses seen in referred colorectal cancer patients, and each one has a common benign explanation that absorbs the symptom before investigation happens. When blood appears in or on the stool, the assumption in most Indian households is haemorrhoids, and while piles are genuinely common, that assumption in practice functions as a reason not to investigate rather than a working diagnosis to confirm, and the colonoscopy that should have followed the very first episode gets deferred indefinitely. Altered bowel habits get absorbed into existing labels a patient with a prior IBS history who develops looser stools, increased urgency, or a shift to alternating constipation and diarrhoea will typically have the new pattern attributed to their existing condition rather than investigated as a change from it, which is exactly the clinical scenario where something early gets missed. Losing weight without trying is the symptom patients most frequently rationalise rather than investigate, particularly when they’re otherwise functional and not expecting a serious diagnosis, and in referred patients it’s routine to find that several kilograms disappeared over a three to four month period before anyone considered an oncological cause. In the lower abdomen, a heaviness or discomfort that antacids don’t resolve and that dietary adjustment hasn’t changed over several weeks is worth a scope rather than another empirical treatment trial, because a tumour causing early partial obstruction produces a picture that’s clinically indistinguishable from functional bloating without one. Any one of these lasting more than three weeks, or two of them appearing together, warrants investigation by a colorectal cancer specialist rather than further empirical management. Why Is Late Diagnosis So Consistent in the Indian Population? Several factors explain why this delay pattern repeats across patients from different backgrounds, ages, and cities, and understanding them is what makes earlier presentations possible. Throughout the months a colorectal cancer grows undiagnosed, the patient typically isn’t ignoring the symptom entirely but is instead managing it actively with a pharmacy product, a dietary change, or a home remedy, which produces enough functional relief to suppress the urgency to investigate further while the underlying disease continues. Talking about bowel function remains a genuine barrier in clinical interactions, and patients who wouldn’t hesitate to describe chest pain in detail will often omit rectal bleeding from a consultation, particularly when the appointment is nominally about something else and nobody asks directly. The absence of organised colorectal screening in India means that most people have never been told to consider a routine colonoscopy at age 45 regardless of symptoms, which is the single most effective structural intervention for catching this cancer early, and without that baseline expectation there’s no default prompt to investigate before something symptomatic develops. If a patient is under 50, the probability of colorectal cancer gets dismissed almost automatically, both by the patient and sometimes by the treating clinician, despite the fact that under-50 colorectal cancer rates are rising in India as they are globally and that younger patients who do present with it often do so at a more advanced stage precisely because of that age-based assumption. Understanding which of these presentations should trigger an urgent referral rather than another repeat consultation is where better outcomes start. Read more on cancer warning signs to know which clinical pictures need a scope without delay. Why Choose Dr. Vipulroy Rathod for Colorectal Cancer? Dr. Vipulroy Rathod has been treating colorectal cancer endoscopically at Fortis Hospital Mulund for over 30 years, and his EUS practice since 1998 means the staging that decides between an endoscopic, laparoscopic, or open route happens accurately in the same workup. Patients referred for open surgery on lesions that were actually suitable for endoscopic removal frequently find a less invasive option available. Physicians from 35 countries have trained under his approach at Fortis.  Book your consultation today with one of India’s most experienced specialists for colorectal cancer screening, symptom evaluation, and endoscopic diagnosis. Book Appointment Call now Frequently Asked Questions What are the early symptoms of colorectal cancer? Blood in stool, unexplained change in bowel habits lasting more than three weeks, persistent bloating, and unintended weight loss are among the earliest signs that are most commonly dismissed. Why do Indians often ignore colorectal cancer symptoms? Most symptoms like bloating, irregular stools, and rectal bleeding are attributed to common conditions like piles or acidity, leading to delayed consultation and late-stage diagnosis. At what age should Indians get screened for colorectal cancer? Screening with colonoscopy is recommended from age 45 for average-risk individuals, and earlier for those with a family history of colorectal cancer or inflammatory bowel disease. Is blood in stool always a sign of colorectal cancer? Not always, but rectal bleeding should never be assumed to be piles without a proper examination, as colonoscopy is the only way to rule out colorectal cancer with certainty. Disclaimer: This blog is intended for informational and educational purposes only and should not be considered medical advice. Please consult a qualified gastroenterologist or healthcare professional for personalized diagnosis and treatment.